Releases

20174 items in section

Embecta Shareholders Face August Deadline in Securities Fraud Action

Investors who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, have until August 17 to participate in a class action lawsuit. The litigation, spearheaded by Schall, Brown & Schwartz LLP, alleges the company misled the market regarding its fiscal performance and financial guidance.

Roblox Faces Securities Fraud Class Action Over Growth Claims

Investors who purchased Roblox Corporation stock between October 30, 2025, and April 30, 2026, are being urged to join a class action lawsuit against the gaming company. Schall, Brown & Schwartz LLP is seeking lead plaintiffs for the action, which alleges the company misled the market regarding its business performance.

First Solar Faces Securities Class Action Over Alleged Misleading Claims

Investors who purchased First Solar shares between February 26, 2025, and February 24, 2026, are now under notice of a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centered on claims that the company misled the market regarding its operational transition from Asia to the United States.

Erasca Faces Securities Class Action Over Misleading Drug Claims

Investors who purchased Erasca, Inc. shares between January 14, 2025, and April 26, 2026, are being urged to join a class action lawsuit. The litigation alleges the company misled the market regarding the development and patent risks associated with its ERAS-0015 therapeutic candidate.

BitGo Holdings Faces Class Action Lawsuit Over IPO Disclosures

Investors who purchased BitGo Holdings stock following its January 22, 2026, initial public offering are being urged to join a class action lawsuit against the company. The litigation alleges that the digital asset firm misled shareholders regarding its financial health and exposure to market volatility during its public debut.

SCU Launches Living Well Column to Bridge Health Science and Daily Life

The Southern California University of Health Sciences is debuting a monthly educational series, Living Well, aimed at translating complex clinical research into accessible guidance for the public. The inaugural installment dissects the physiological toll of chronic stress, moving beyond emotional symptoms to address systemic bodily impacts.

FIC Global Unveils Johor-Singapore Cross-Border Manufacturing Strategy

Taiwanese technology group FIC Global has launched a dual-partnership initiative to anchor its manufacturing and supply chain operations within the Johor–Singapore Special Economic Zone. By pairing Malaysian industrial production with Singaporean innovation, the company aims to build a more resilient cross-border model for global high-tech markets.

Schall, Brown & Schwartz Launches Investigation into OIEIX Fund

Investors in the JPMorgan Equity Income Fund (OIEIX) are now under legal scrutiny as the Los Angeles-based firm Schall, Brown & Schwartz LLP probes potential securities law violations. The inquiry centers on whether the fund misled shareholders or withheld critical financial information necessary for informed investment decisions.

PepsiCo APAC Partners with Envision for Low-Carbon Fertilizer Credits

PepsiCo APAC has secured a landmark agreement to purchase environmental attribute certificates for 1,000 tonnes of low-carbon ammonia from Envision Energy. By decoupling environmental benefits from physical supply, the deal creates a scalable model to address Scope 3 emissions in agricultural supply chains without disrupting existing logistics.

Rackspace Technology Faces Securities Class Action Over AI Pivot

Investors who held Rackspace Technology, Inc. stock between May 7 and July 8, 2026, are being sought for a class action lawsuit. Schall, Brown & Schwartz LLP claims the company misled shareholders regarding the financial impact of shifting resources from its profitable Private Cloud business toward enterprise AI initiatives.

Hims & Hers Health Faces Shareholder Investigation Following FTC Lawsuit

Shareholders of Hims & Hers Health are under scrutiny by litigation firm Schall, Brown & Schwartz following federal allegations that the company mishandled sensitive consumer data. The investigation centers on whether the firm misled investors by failing to disclose deceptive privacy, billing, and cancellation practices prior to a recent FTC legal action.

Investors Target Insulet Corporation in New Securities Class Action

Investors who purchased Insulet Corporation shares between February 21, 2025, and May 26, 2026, are facing a critical deadline as a class action lawsuit moves forward. The litigation centers on allegations that the company misled the market regarding the integrity of its manufacturing processes and associated safety protocols.

Rackspace Faces Securities Litigation Over AI Resource Shift

Investors who held Rackspace Technology shares between May 7 and July 8, 2026, are being sought for a class action lawsuit. The legal action centers on allegations that the company misled the market by prioritizing AI growth at the expense of its stable, profitable Private Cloud business segment.

Shareholders Target Peabody Energy Over Centurion Mine Misstatements

Investors who purchased Peabody Energy stock between October 14, 2024, and May 4, 2026, face an August 24 deadline to join a class action lawsuit. The litigation alleges the coal producer misled the market regarding production timelines at its Centurion mine while the site struggled with persistent operational delays.

Insulet Corporation Faces Securities Fraud Class Action Lawsuit

Investors who purchased Insulet Corporation securities between February 21, 2025, and May 26, 2026, face an August 31, 2026, deadline to join a class action lawsuit. The litigation, filed by Schall Brown & Schwartz LLP, alleges the company misled the market regarding manufacturing defects and safety compliance.

Investors Target Futu Holdings in Securities Class Action

Futu Holdings Limited faces a class action lawsuit alleging the company misled shareholders regarding its regulatory compliance in China. The legal challenge centers on claims that the firm operated without necessary approvals from the China Securities Regulatory Commission, triggering potential violations of the Securities Exchange Act of 1934.

GeneDx Faces Securities Fraud Lawsuit Over Impairment Disclosures

Investors who purchased GeneDx Holdings Corp. securities between April 16, 2025, and May 4, 2026, face an August 3, 2026, deadline to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centering on misleading financial disclosures that purportedly obscured the firm's true performance.

Zillow Faces Securities Class Action Over Alleged Redfin Misstatements

Investors who purchased Zillow Group, Inc. stock between February 11, 2025, and May 7, 2026, face an August 10, 2026, deadline to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, targets alleged misrepresentations regarding the company’s relationship with Redfin.

Investors Urged to Join Securities Fraud Class Action Against Via Transportation

Shareholders who purchased Via Transportation, Inc. stock following the company’s September 2025 initial public offering have until August 10, 2026, to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation targets alleged misrepresentations regarding the firm's financial health and exposure to volatile digital asset markets.

Investors Target ADMA Biologics in Securities Fraud Class Action

A federal class action lawsuit now challenges ADMA Biologics, accusing the company of inflating its financial health through deceptive trade practices between August 9, 2024, and March 25, 2026. The DJS Law Group is currently organizing shareholders who incurred losses during this period to seek potential legal recovery.

Investors Target GRAIL Inc. in Securities Fraud Class Action

Investors who held GRAIL, Inc. shares between May 13, 2025, and February 19, 2026, face an August 4 deadline to join a class action lawsuit. The litigation alleges the company misled the market by masking unfavorable results from its NHS-Galleri clinical trial while publicly promoting the study’s success.

SAINT BELLA Launches In-Home Postpartum Care in Southern California

For families navigating the transition to parenthood, the choice between traditional confinement centers and independent recovery at home often feels like a compromise. SAINT BELLA is now bridging that gap, launching a 28-day, in-home postpartum program in Irvine and Newport Beach to bring clinical and traditional support directly to the residence.

Investors Eye Class Action Against Black Rock Coffee Bar

Investors who purchased Black Rock Coffee Bar stock between September 12, 2025, and May 12, 2026, face an August 17 deadline to join a securities fraud lawsuit. Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs to represent shareholders in the case against the NASDAQ-listed company.

Investors Urged to Join Securities Class Action Against ZoomInfo

Investors who purchased ZoomInfo Technologies Inc. stock between November 3, 2025, and May 11, 2026, face an August 24, 2026, deadline to seek lead plaintiff status in a pending securities fraud lawsuit, according to the national shareholder rights firm Schall, Brown & Schwartz LLP.

PepsiCo APAC Targets Scope 3 Emissions via Green Ammonia Certificates

PepsiCo APAC has secured a multi-year deal with Envision Energy to purchase low-carbon ammonia environmental attribute certificates, a strategic move to lower the carbon footprint of its agricultural supply chain. By decoupling environmental attributes from physical product delivery, the agreement aims to bypass logistical hurdles in decarbonizing fertilizer inputs.

Badger Meter Faces Securities Class Action Over Revenue Reporting

Investors who held Badger Meter, Inc. stock between April 18, 2024, and April 16, 2026, face an August 3 deadline to join a class action lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding the true drivers of its financial performance.

Investors Target Embecta Over Alleged Securities Fraud

Shareholders who acquired Embecta Corp. stock between November 25, 2025, and May 4, 2026, are facing a ticking clock as the DJS Law Group rallies claimants for a class action lawsuit. The litigation centers on allegations that the company misled the market regarding the stability of its pen needle business.

CellOrigin Targets Solid Tumors with New CAR-Mix and TMT Engager Tech

At the 2026 ASCO Annual Meeting, Hangzhou-based CellOrigin unveiled two advanced solid-tumor therapies while securing a strategic partnership with Walvax Biotechnology. The move signals a shift toward in vivo and multi-cell approaches, aiming to bypass the antigen heterogeneity that historically hampers T-cell treatments in aggressive cancers like ovarian and liver carcinoma.